We Are Removing Teladoc (TDOC) from Investing Ideas

02/15/18 10:40AM EST

"Teladoc has been a good idea that I think we can come back to lower," Hedgeye CEO Keith McCullough writes. "This is mainly a market call in addition to TDOC signaling immediate-term #overbought."

***No change to Healthcare analyst Tom Tobin's fundamental long thesis on Teladoc. Click here to read our analyst's original report.

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.